SPU [Future FinTech] 8-K:
[]
HGSH [CHINA HGS REAL ESTATE] 8-K: (Original Filing)
[China HGS Reports Full Year Financial Results for the Fiscal Year 2017 HANZHONG, CHINA January 3, 2018 Highlights for the Fiscal 2017 l Total revenues for the fiscal 2017 were approximately $58.7 million, an increase of approximately 45% from approximately $40.6 million in fiscal 2016. l For the Com]
HGSH [CHINA HGS REAL ESTATE] 8-K: China HGS Reports Full Year Financial Results for
[China HGS Reports Full Year Financial Results for the Fiscal Year 2017 HANZHONG, CHINA January 3, 2018 Highlights for the Fiscal 2017 l Total revenues for the fiscal 2017 were approximately $58.7 million, an increase of approximately 45% from approximately $40.6 million in fiscal 2016. l For the Com]
BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)
[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): December 28, 2017 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identificati]
